Patents
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
02/2003
02/04/2003US6514944 Macrolide antiinfective agents
01/2003
01/30/2003WO2002013836A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient
01/30/2003US20030023053 Process to obtain clarithromycin
01/30/2003CA2417845A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient
01/29/2003EP1279703A1 Food colouring substances based on Anthocyanin
01/29/2003EP1278881A1 Hybrid glycosylated products and their production and use
01/29/2003EP1278527A1 Derivatives of polyene macrolides and preparation and use thereof
01/29/2003EP1112280B1 Method of preparing form ii crystals of clarithromycin
01/29/2003EP0874863B1 3-deoxy-3-descladinose derivatives of erythromycins a and b
01/28/2003US6512100 Chromogenic substrates of sialidase and methods of making and using the same
01/27/2003WO2002014339A1 Process for producing erythromycin derivative
01/27/2003WO2002010144A1 Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
01/27/2003CA2417319A1 Process for producing erythromycin derivative
01/23/2003WO2002060436A3 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states
01/23/2003US20030018056 Sodium channel moderators; cardiovascular disorders; antidiabetic agents
01/22/2003EP1276747A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
01/21/2003US6509455 Recombinant narbonolide polyketide synthase
01/21/2003US6509372 Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin
01/16/2003WO2003004509A2 C12 modified erythromycin macrolides and ketolides having antibacterial activity
01/16/2003WO2003004059A1 Treatment of parasitic disease
01/16/2003WO2002032916A3 Sixteen-membered macrolide compounds
01/16/2003US20030013870 Carbopeptoids and carbonucleotoids
01/16/2003US20030013860 Azalide isomers, water, and acids
01/16/2003US20030013665 Novel macrolide antibiotics
01/16/2003US20030013663 Therapy for bacteria infections that are drug resistant
01/16/2003US20030013662 Novel polyketide derivatives and recombinant methods for making same
01/16/2003CA2451742A1 Treatment of parasitic disease
01/16/2003CA2451391A1 C12 modified erythromycin macrolides and ketolides having antibacterial activity
01/15/2003EP1274712A1 Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition
01/15/2003EP1165582B1 Novel method for the production of etoposide
01/15/2003EP1165581B1 Method for the production of 4'-demethyl - 4'-phosphate-2",3" - bis pentafluorophenoxyacetyl - 4",6"-ethylidene - beta-d- glucoside epipodophyllotoxin and the salts thereof
01/15/2003EP1098901B1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
01/15/2003CN1391578A B-D-5-thioxylose derivatives, preparation method and therapeutic use
01/14/2003US6506886 Treating with mixture of water and immiscible solvent; isolation by filtration; crystallization
01/14/2003US6506765 Apomorphine derivatives and methods for their use
01/14/2003CA2294928C Production of avermectin compounds
01/14/2003CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
01/08/2003EP1272500A2 Process for preparing 6-o-alkenyl-subsituted erythromycin derivatives
01/08/2003CN1390226A Preparation of a macrocyclic lactone
01/08/2003CN1098272C Process for synthesizing clamycin as antibiotic medicine
01/07/2003US6504035 3-deoxy-desmycosin derivatives and process for their preparation
01/07/2003US6504017 Erthromycin a oxime solvates
01/07/2003CA2192481C Drug salts
01/07/2003CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections
01/03/2003WO2003000712A1 Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
01/03/2003WO2003000711A1 Antimitotic eleuthesides
01/03/2003WO2003000674A1 Process for producing soluble isoflavone-containing composition
01/03/2003WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
01/03/2003WO2002032918A3 Ketolide antibacterials
01/03/2003WO2002009699A3 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
01/03/2003CA2455300A1 Nitrogen-containing heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
01/03/2003CA2451511A1 Antimitotic eleuthesides
01/02/2003US20030004117 Methods for inhibiting angiogenesis
01/02/2003EP1073648A4 12,13-modified epothilone derivatives
01/02/2003EP1073647A4 12,13-cyclopropane epothilone derivatives
01/01/2003CN1097460C Amino sugar and related sugar derivatives of cytotoxic of indolopyrro locarbazoles
12/2002
12/31/2002US6500960 Method to produce novel polyketides
12/31/2002US6500936 Glycerol culture of actinomyces
12/27/2002WO2002102819A1 Process for preparation of an erythromycin compound
12/27/2002WO2002102818A1 Process for preparation of erythromycin compounds
12/26/2002US20020198225 Administering a competitive inhibitor of the enzyme in an amount effective to enhance enzyme activtiy, selected from 2,5-dideoxy- 2,5-imino-D-mannitol, 3,4-diepi- alpha -homonojirimycin, 5-O- deoxyglactonojirimycin, calystegines
12/26/2002US20020198193 Novel 5-thio-B-D-xylopryanoside derivatives, preparation, method, pharmaceutical compositions containing them and their therapeutic use
12/26/2002US20020197648 High throughput screening methods using magnetic resonance imaging agents
12/25/2002CN1386742A Flavone derivatives and preparing process and use thereof
12/25/2002CN1096862C Controlled-release dosage form of azithromycin
12/24/2002US6498146 Erythromycin derivatives
12/19/2002US20020193320 For therapy of bacterial infections
12/19/2002US20020192756 Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
12/19/2002US20020192709 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
12/18/2002EP1266905A1 Process for producing purified erythromycin
12/18/2002EP1265909A2 Process for the preparation of 6-o-propargyl erythromycin derivatives
12/18/2002EP1265908A1 Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin a derivatives from 9-deoxo-9(z)-hydroxyiminoerythromycin a
12/18/2002EP0930889B1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
12/18/2002CN1096468C Adriamycin polybasic acid sodium salt complex salt
12/17/2002US6495524 Benzo[b]pyran derivatives useful as external agents for the skin
12/17/2002US6495141 Recovery of isoflavones from soy molasses
12/12/2002WO2002098893A1 Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
12/11/2002CN1384838A Macrolide antinfective agents
12/11/2002CN1384108A Prepn process of 4''-substituted 9-deoxy-9A aza-9A homoerythromycin derivative
12/05/2002WO2002097082A2 Engineered biosynthesis of novel polyenes
12/05/2002WO2002097062A2 Recombinant narbonolide polyketide synthase
12/05/2002WO2002096922A1 An arylation method for the functionalization of o-allyl erythromycin derivatives
12/05/2002US20020183264 Use of harpagid-related compounds for prevention and treatment of osteoporosis, arthritis and ruptured disc and pharmaceutical composition containing the same
12/05/2002US20020183262 Method for purification of acarbose
12/05/2002CA2449173A1 An arylation method for the functionalization of o-allyl erythromycin derivatives
12/04/2002EP0891370B1 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin a derivatives
12/04/2002CN1383381A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives
12/04/2002CN1382375A Pediculus and nit killing compsns. and method for killing head pediculus and its nit
11/2002
11/28/2002WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002WO2002036601A3 Phase transfer catalyzed glycosidation of an indolocarbazole
11/28/2002CA2447231A1 Methods for inhibiting angiogenesis
11/27/2002EP1260517A1 Process for preparing flavonoids
11/27/2002EP1259923A2 Anti-infective agents useful against mulitidrug-resistant strains of bacteria
11/27/2002EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002CN1381459A Deacidified gingko leaf and its extract and its preparing process and application
11/26/2002US6486195 Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
11/26/2002CA2261106C Process for preparing erythromycin derivative, such as roxithromycin, from the corresponding oxime
11/26/2002CA2198994C Foaming coffee creamer and instant hot cappuccino
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 117